Post-myocardial infarction patients: a comparison of management by a physician and a cardiologist according to the REGATA register
https://doi.org/10.15829/1728-8800-2020-2525
Abstract
Aim. To assess the quality of diagnostics and treatment of outpatients with a history of myocardial infarction (MI) according to REGATA register.
Material and methods. In 2012-2013, 481 patients with a MI history who sought help in ambulatory care clinic were included in the study. In 87,5% of cases, the reference visit was to a physician or cardiologist, in 12,5% — to other specialist. The median age was 72 [62; 78] years (men — 51,4% (n=247)). The median time of previous MI was 5 [2; 9] years before the inclusion date.
Results. A total of 23,5% of patients with previous MI had never visited a cardiologist before, 37% of patients visited a cardiologist in the last 12 months before being included in the registry. The use of diagnostic tests was insufficient, regardless of specialty of a doctor managing a patient. In patients managed by a cardiologist, electrocardiography, 24-hour Holter ECG monitoring, echocardiography, exercise tolerance test were much more often used. Cardiovascular agents were prescribed at the last visit to a physician and/or cardiologist in 91,9% of cases. Angiotensin converting enzyme inhibitors were used in 49,6% of patients, sartan medicines — 25,6%, beta-blockers — 57,7%, calcium channel antagonists — 21,7%, long-acting nitrates — 20,0%, statins — 45,1 %, antiplatelet agents — 67,3%. In patients who visited/not visited a cardiologist, the frequency of prescribing cardiovascular agents did not significantly differ, except for statins (50,0% vs 23,9%, respectively (p<0,0001)).
Conclusion. The results obtained indicate that quality of managing outpatients after MI is higher by cardiologists than by physicians. However, the use of diagnostic tests and cardiovascular agents is insufficient, regardless of specialty of a doctor managing a patient.
About the Authors
K. G. PereverzevaRussian Federation
Ryazan
S. S. Yakushin
Russian Federation
Ryazan
A. I. Gracheva
Russian Federation
Ryazan
M. M. Lukyanov
Russian Federation
Moscow
O. M. Drapkina
Russian Federation
Moscow
References
1. Drapkina OM, Samorodskaya IV, Starinskaya MA, Boytsov SA. Comparison of Russian regions by standardized mortality rates from all causes and circulatory system diseases in 2006-2016. The Russian Journal of Preventive Medicine and Public Health 2018;21(4):4-12. (In Russ.) doi:10.17116/profmed20182144.
2. Danilov AV, Kobzar II, Nagibin OA, et al. Morbidity and mortality from cardiovascular diseases in Ryazan district: 2014-2018. Science of the young (Eruditio Juvenium). 2019;7(3):439-49. (In Russ.) doi:10.23888/HMJ201973439-449.
3. Demographic Yearbook of Russia. 2019: Stat.sat. Rosstat. M., 2019. 252 р. (In Russ.)
4. Gafarov VV, Gafarova AV. World health organization program “acute myocardial infarction register” as audit health assessment Vestnik NSUEM. 2015;(4):200-22. (In Russ.)
5. Titova EYa. Personnel policy in healthcare: risks and solutions Health Risk Analysis 2017;(1):125-31. (In Russ.) doi:10.21668/health.risk/2017.1.14.
6. Boytsov SA, Martsevich SYu, Kutishenko NP, et al. Registers in cardiology: Their principles, rules, and real-word potential. Cardiovascular Therapy and Prevention. 2013;12(1):4-9. (In Russ.) doi:10.15829/1728-8800-2013-1-4-9.
7. 2013 ESH/ESC guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of Cardiology (ESC) Russ J Cardiol. 2014;(1):7-94. (In Russ.) doi:10.15829/1560-4071-2014-1-7-94.
8. Loukianov MM, Boytsov SA, Yakushin SS, et al. Diagnostics, treatment, associated cardiovascular and concomitant noncardiac diseases in patients with diagnosis of “atrial fibrillation” in real outpatient practice (according to data of registry of cardiovascular diseases, RECVASA). Rational Pharmacotherapy in Cardiology. 2014;10(4):366-77. (In Russ.) doi:10.20996/1819-6446-2014-10-4-366-377.
9. Garganeeva AA, Kuzheleva EA, Efimova EV, Tukish OV. Drug therapy of patients with myocardial infarction as the most important component of a polyclinic stage of cardiorehabilitation. CardioSomatica. 2015;6(3):22-6. (In Russ.)
10. Pereverzeva KG, Vorobev AN, Nikulina NN, et al. Features of examination of patients with coronary heart disease in outpatient practice according to observation in a registry study Pavlov Russian Medical Biological Herald. 2014;22(1):90-6. (In Russ.) doi:10.17816/PAVLOVJ221.
11. Guidelines for dispensary observation of patients with chronic non-communicable diseases and patients with a high risk of their development. (SA Boytsov, AG Chuchalin, eds). Moscow, 2014. 112 р. http://diaregistry.ru/assets/files/documents/Dispansernoe-nablyudenie-bolnih-hronicheskimi-NIZ-2014.pdf (17 mar 2020) (In Russ.)
12. Order of the Ministry of Health of the Russian Federation dated March 29, 2019 No. 173n “On approval of the procedure for conducting dispensary monitoring for adults”. http://www.garant.ru/hotlaw/federal/1271073/ (In Russ.)
13. Order of the Ministry of Health of the Russian Federation of December 21, 2012 N 1344н “On approval of the Procedure for the Dispensary Monitoring” http://base.garant.ru/70321224/ (In Russ.)
Review
For citations:
Pereverzeva K.G., Yakushin S.S., Gracheva A.I., Lukyanov M.M., Drapkina O.M. Post-myocardial infarction patients: a comparison of management by a physician and a cardiologist according to the REGATA register. Cardiovascular Therapy and Prevention. 2020;19(3):2525. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2525